Side effects of Obynal-M in details
Discontinue administration of Obynal-M and consult a doctor if the following symptoms occur: Pruritus, eruption, flare, erythema, xeroderma, nausea, vomiting, diarrhea, constipation, epigastric distress, anorexia, abdominal distention, epigastralgia, photosensitivity, convulsion, fever, coma, asystole, CNS dysfunction, hyperkalemia, pulmonary edema and urticaria.
May cause acceleration of menstruation and menorrhagic extension of anovulatory menstrual cycle; thrombosis or thrombotic predisposition in patients concomitantly taking oral contraceptives; nausea, vomiting, hypernatremia, congestive heart failure and edema when administered at high doses; hypercalcemia and nephrolithiasis on long-term use.
Obynal-M contraindications
Hypersensitivity to Obynal-M.
Combination therapy with aldosterone antagonist and triamterene may cause hypercalcemia.
Patients with hypercalcemia, hyperkalemia, sarcoidosis, nephrolithiasis, severe renal failure, Wilson's disease, hematochromatosis and those taking oral tetracyclines, antacids, phosphates and levodopa.
Infants <1 year.
Do not administer before and after drinking teas containing tannins.
References
- DailyMed. "ASCORBIC ACID; BIOTIN; CYANOCOBALAMIN; DEXPANTHENOL; ERGOCALCIFEROL; FOLIC ACID; NIACINAMIDE; PHYTONADIONE; PYRIDOXINE HYDROCHLORIDE; RIBOFLAVIN 5'-PHOSPHATE SODIUM; THIAMINE HYDROCHLORIDE; VITAMIN A; VITAMIN E: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "COPPER: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DTP/NCI. "folic acid: The NCI Development Therapeutics Program (DTP) provides services and resources to the academic and private-sector research communities worldwide to facilitate the discovery and development of new cancer therapeutic agents.". https://dtp.cancer.gov/dtpstandard/s... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Obynal-M are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Obynal-M. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported side effects
No survey data has been collected yetConsumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
